80 related articles for article (PubMed ID: 38506253)
1. Collagen synthase P4HA3 as a novel biomarker for colorectal cancer correlates with prognosis and immune infiltration.
Guo X; Zhang Y; Peng L; Wang Y; He CW; Li K; Hao K; Li K; Wang Z; Huang H; Miao X
Heliyon; 2024 Jun; 10(11):e31695. PubMed ID: 38832271
[TBL] [Abstract][Full Text] [Related]
2. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
Luo R; Song J; Zhang W; Ran L
Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
[TBL] [Abstract][Full Text] [Related]
3. Differences in T cell immune-related lncRNA and mRNA expression patterns between right- and left-sided colorectal cancers.
Lijuan Y; Yinhang W; Yangyanqiu W; Xiaohui H; Yunhai W; Shuwen H
Hum Immunol; 2021 Dec; 82(12):950-959. PubMed ID: 34426030
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T-cell costimulator as a crucial immune checkpoint molecule.
Chu J; Wu Y; Qu Z; Zhuang J; Liu J; Han S; Wu W; Han S
Cancer Med; 2024 Mar; 13(6):e7097. PubMed ID: 38506253
[TBL] [Abstract][Full Text] [Related]
5. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
[TBL] [Abstract][Full Text] [Related]
6. Multidimension Analysis of the Prognostic Value, Immune Regulatory Function, and ceRNA Network of LY6E in Individuals with Colorectal Cancer.
Li T; Liu W; Wang C; Wang M; Hui W; Lu J; Gao F
J Immunol Res; 2022; 2022():5164265. PubMed ID: 35310607
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of lncRNA-associated ceRNA network in colorectal cancer.
Yuan W; Li X; Liu L; Wei C; Sun D; Peng S; Jiang L
Biochem Biophys Res Commun; 2019 Jan; 508(2):374-379. PubMed ID: 30503344
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of the functions and clinical implications of exosome circRNAs in colorectal cancer.
Lei T; Zhang Y; Wang X; Liu W; Feng W; Song W
Front Immunol; 2022; 13():919014. PubMed ID: 35924235
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer statistics, 2023.
Siegel RL; Wagle NS; Cercek A; Smith RA; Jemal A
CA Cancer J Clin; 2023; 73(3):233-254. PubMed ID: 36856579
[TBL] [Abstract][Full Text] [Related]
11. Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
Khaliq AM; Erdogan C; Kurt Z; Turgut SS; Grunvald MW; Rand T; Khare S; Borgia JA; Hayden DM; Pappas SG; Govekar HR; Kam AE; Reiser J; Turaga K; Radovich M; Zang Y; Qiu Y; Liu Y; Fishel ML; Turk A; Gupta V; Al-Sabti R; Subramanian J; Kuzel TM; Sadanandam A; Waldron L; Hussain A; Saleem M; El-Rayes B; Salahudeen AA; Masood A
Genome Biol; 2022 May; 23(1):113. PubMed ID: 35538548
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Shitara K; Ajani JA; Moehler M; Garrido M; Gallardo C; Shen L; Yamaguchi K; Wyrwicz L; Skoczylas T; Bragagnoli AC; Liu T; Tehfe M; Elimova E; Bruges R; Zander T; de Azevedo S; Kowalyszyn R; Pazo-Cid R; Schenker M; Cleary JM; Yanez P; Feeney K; Karamouzis MV; Poulart V; Lei M; Xiao H; Kondo K; Li M; Janjigian YY
Nature; 2022 Mar; 603(7903):942-948. PubMed ID: 35322232
[TBL] [Abstract][Full Text] [Related]
13. A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner.
El-Sayes N; Vito A; Salem O; Workenhe ST; Wan Y; Mossman K
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163675
[TBL] [Abstract][Full Text] [Related]
14. Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts.
Bortolomeazzi M; Keddar MR; Montorsi L; Acha-Sagredo A; Benedetti L; Temelkovski D; Choi S; Petrov N; Todd K; Wai P; Kohl J; Denner T; Nye E; Goldstone R; Ward S; Wilson GA; Al Bakir M; Swanton C; John S; Miles J; Larijani B; Kunene V; Fontana E; Arkenau HT; Parker PJ; Rodriguez-Justo M; Shiu KK; Spencer J; Ciccarelli FD
Gastroenterology; 2021 Oct; 161(4):1179-1193. PubMed ID: 34197832
[TBL] [Abstract][Full Text] [Related]
15. The Next Decade of Immune Checkpoint Therapy.
Sharma P; Siddiqui BA; Anandhan S; Yadav SS; Subudhi SK; Gao J; Goswami S; Allison JP
Cancer Discov; 2021 Apr; 11(4):838-857. PubMed ID: 33811120
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
